Bempedoic acid/Ezetimibe Prescribing at MODALITY PARTNERSHIP (AWC)
Lipid-regulating drugs | Cardiovascular System
Items (12m)
511
Total Quantity
16.1K
NHS Cost
£30.2K
vs National Avg
+736.8%
MODALITY PARTNERSHIP (AWC) prescribed 511 items of Bempedoic acid/Ezetimibe over the last 12 months at a cost of £30,233 to the NHS. This is 736.8% above the national average prescribing rate. Bempedoic acid/Ezetimibe is classified under Lipid-regulating drugs in the BNF.
Monthly Prescribing Trend
Jun 2026
41
Jun 2026
34
Jun 2026
46
Jun 2026
36
Jun 2026
38
Jun 2026
46
Jun 2026
39
Jun 2026
40
Jun 2026
48
Jun 2026
43
Jun 2026
46
Jun 2026
54
Prescribing Details
| Total Items | 511 |
|---|---|
| Total Quantity | 16,070 |
| Total NHS Cost | £30,233 |
| Presentations | 2 different forms |
| vs National Average | +736.8% |
Bempedoic acid/Ezetimibe Prescribing Comparison
| This practice | 511 items |
|---|---|
| National average per practice | 61 items |
| Difference | +736.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.